Genetic variation in HLA, IGKV and HHEX loci influence mRNA vaccine-induced long-lasting humoral protection against COVID-19

Résumé fourni par la source

Abstract There is a notable variability in the humoral response mounted across individuals after COVID-19 vaccination. A growing number of studies link genetic factors to antigen-specific antibody levels after the first two immunizations. However, knowledge on the potential influence of genetics on the neutralizing activity of vaccine-induced antibodies and the humoral immune response to the third immunization is limited. Here, we performed genome-wide association studies on antigen-specific antibody concentrations and live-virus neutralization activities after two and three doses of COVID-19 vaccines across two German cohorts of SARS-CoV-2 infection-naïve individuals (RisCoin study n=2877; KoCo19 study n=1654). We found the Human leukocyte antigen (HLA) locus to be associated with differential live-virus neutralizing and anti-SARS-CoV-2 spike antibodies after both the second and third vaccinations. Consistent with its effect on third-dose neutralizing antibodies the HLA locus was further associated with a lower incidence of breakthrough infections, indicating sustained protection. We confirmed the association of the Immunoglobulin kappa variable cluster (IGKV) with antibody concentrations after two vaccinations and discovered a novel association in the Hematopoietically expressed homeobox (HHEX) locus. Studying HLA, IGKV, and HHEX may clarify mechanisms of variable humoral immunity and contribute towards personalized vaccination strategies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.